Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Accrued Liabilities - Accrued Liabilities (Details)

v3.10.0.1
Note 5 - Accrued Liabilities - Accrued Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2018
Jan. 01, 2018
Dec. 31, 2017
Accrued sales commission $ 1,292   $ 1,067
Accrued bonuses 922   1,597
Accrued interest 676   447
Accrued payroll and other related expenses 527   488
Accrued professional fees 386   562
Customer contracts liabilities 334  
Travel and entertainment 230   156
Accrued sales & use tax 143   149
Accrued clinical trial costs 76   30
Other accruals 539   109
Total accrued liabilities $ 5,125 $ 4,623 $ 4,605 [1]
[1] The condensed consolidated balance sheet as of December 31, 2017 has been derived from the audited consolidated financial statements as of that date.